Jazz Pharmaceuticals
JAZZ
JAZZ
453 hedge funds and large institutions have $7.37B invested in Jazz Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 140 increasing their positions, 173 reducing their positions, and 100 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
30% less call options, than puts
Call options by funds: $66.5M | Put options by funds: $95.4M
46% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 100
75% less funds holding in top 10
Funds holding in top 10: 8 → 2 (-6)
Holders
453
Holding in Top 10
2
Calls
$66.5M
Puts
$95.4M
Top Buyers
| 1 | +$140M | |
| 2 | +$97.6M | |
| 3 | +$87.2M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$74.9M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$62.8M |
Top Sellers
| 1 | -$119M | |
| 2 | -$72.5M | |
| 3 | -$62.6M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$46.3M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$45M |